Don't Become 'Unnerved' About Regenerative Medicine

[manouli]

Companies can make a lot of money with us when they help us to cure our spinal cord injury because is a perpetual problem and they always will be busy. People daily getting spinal cord injury and they need to recover.


Don't Become 'Unnerved' About Regenerative Medicine
August 9, 2012 by: Cockrell Group | about: AXGN.OB, includes: BAX, JNJ, NVIV.OB, SHPGF.OB

Spinal cord and peripheral nerve injuries have long been among the most difficult to repair because of the lack of medical technology innovation available to treat them. However, many advances being made in stem cell research and the regenerative medicine space have positioned both small and large companies on the cutting edge of medical innovation.

As the markets for these smaller companies develop, larger, mega-cap medical technology companies have been turning their sights to companies that have innovative products in early developing markets. These companies have been actively searching for acquisition targets in the regenerative medicine space. The takeout multiple for regenerative medicine companies has been in the range of five to seven times revenues.

Highlighted in this piece are a few of the products that publicly-traded companies in this area are selling that make them attractive to investors who want to get in on this small, but growing market.

Although there are several companies in various stages of FDA approval, AxoGen (AXGN.OB) is a unique player within its peer group as its innovative technology is commercially available. AxoGen is establishing its self as a formidable player in peripheral nerve repair and regeneration through the roll out of several proprietary Avance and AxoGuard products.

continue...

http://seekingalpha.com/article/7942...tive-medicine?

[Christin L]

Thanks! The article says that 7,000 persons have been treated with Axogens product. Anyone who can tell about it, or know about someone who´s been treated?

Christin